Stellantis' 1.2M Ram Trucks Under Scrutiny for BTSI Failures
STLA carries a Zacks Rank #3 (Hold) at present.Some better-ranked stocks in the auto space are Strattec Security Corporation STRT, Aisin Corporation ASEKY and Dana Incorporated DAN. While STRT and ASEKY sport a Zacks Rank #1 (Strong Buy) each, DAN carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank stocks here.The Zacks Consensus Estimate for STRT's fiscal 2025 sales and earnings implies year-over-year growth of 3.49% and 8.11%, respectively. EPS estimates for fiscal 2025 and 2026 have improved 73 cents and 91 cents, respectively, in the past 60 days.The Zacks Consensus Estimate for ASEKY's fiscal 2026 sales and earnings implies year-over-year growth of 6.3% and 62.22%, respectively. EPS estimates for fiscal 2026 and 2027 have improved 34 cents and 47 cents, respectively, in the past 60 days. The Zacks Consensus Estimate for DAN's 2025 earnings implies year-over-year growth of 65.96%. EPS estimates for 2025 and 2026 have improved 26 cents and 11 cents, respectively, in the past 30 days.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Dana Incorporated (DAN) : Free Stock Analysis Report
Strattec Security Corporation (STRT) : Free Stock Analysis Report
Aisin Seiki Co. Ltd. Unsponsored ADR (ASEKY) : Free Stock Analysis Report
Stellantis N.V. (STLA) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Crown Holdings (CCK) Earnings Expected to Grow: Should You Buy?
The market expects Crown Holdings (CCK) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 21. On the other hand, if they miss, the stock may move lower. While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. This packaging company is expected to post quarterly earnings of $1.86 per share in its upcoming report, which represents a year-over-year change of +2.8%. Revenues are expected to be $3.14 billion, up 3.2% from the year-ago quarter. The consensus EPS estimate for the quarter has been revised 0.51% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts. Price, Consensus and EPS Surprise Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only. A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). For Crown, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.27%. On the other hand, the stock currently carries a Zacks Rank of #3. So, this combination indicates that Crown will most likely beat the consensus EPS estimate. While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that Crown would post earnings of $1.22 per share when it actually produced earnings of $1.67, delivering a surprise of +36.89%. Over the last four quarters, the company has beaten consensus EPS estimates four times. An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Crown appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Crown Holdings, Inc. (CCK) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 minutes ago
- Yahoo
Can CorMedix (CRMD) Keep the Earnings Surprise Streak Alive?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering CorMedix (CRMD), which belongs to the Zacks Medical - Biomedical and Genetics industry. When looking at the last two reports, this pharmaceutical and medical device company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 24.71%, on average, in the last two quarters. For the last reported quarter, CorMedix came out with earnings of $0.3 per share versus the Zacks Consensus Estimate of $0.25 per share, representing a surprise of 20.00%. For the previous quarter, the company was expected to post earnings of $0.17 per share and it actually produced earnings of $0.22 per share, delivering a surprise of 29.41%. For CorMedix, estimates have been trending higher, thanks in part to this earnings surprise history. And when you look at the stock's positive Zacks Earnings ESP (Expected Surprise Prediction), it's a great indicator of a future earnings beat, especially when combined with its solid Zacks Rank. Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. CorMedix currently has an Earnings ESP of +20.00%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #3 (Hold) indicates that another beat is possibly around the corner. With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss. Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate. Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CorMedix Inc (CRMD) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
5 minutes ago
- Yahoo
Fastenal Q2 Earnings & Sales Beat Estimates, Stock Rises
Fastenal Company's FAST second-quarter 2025 adjusted earnings and revenues came ahead of the Zacks Consensus Estimate and increased year over results reflect operational discipline, customer expansion and resilience despite broader macro sluggishness. FAST stock gained 3.3% after the earnings results on Friday. The company reported earnings per share (EPS) of 29 cents, which beat the Zacks Consensus Estimate of 28 cents and grew 12.7% from the year-ago level of 25 cents per sales rose 8.6% year over year to $2.08 billion, topping the consensus mark of $2.06 billion. Daily sales also climbed 8.6%, driven primarily by improved customer contract momentum and increased unit sales. Growth came despite a sluggish industrial environment, as larger contract customers and key manufacturing accounts continued to drive incremental gains. Foreign exchange rates positively impacted sales by 10 basis points (bps).Fastenal's unit sales rose in the quarter, driven by more customer sites spending more than $10K per month and modest growth in average sales per site. Product pricing also contributed positively, adding 140–170 bps to net sales. Fastenal Company price-consensus-eps-surprise-chart | Fastenal Company Quote Daily sales of Fasteners (mainly used for industrial production and accounting for approximately 30.5% of net sales) increased 6.6% year over year. Sales of Safety Supplies (22.2%) grew 10.7% daily. Sales of the Other Product Lines (47.3%) also increased 9% year over an end-market basis, the daily sales rate of Heavy Manufacturing (which accounted for approximately 42.9% of net sales) rose 7.5% year over year. The daily sales rate of Other Manufacturing (33%) grew 11% compared with the prior the daily sales of Non-Residential Construction grew 3% compared with the prior-year quarter, while the same for Other End-Markets grew 8.7% in the same time sales through weighted FMI devices grew 14.4% for the second quarter, representing 44.1% of net sales. In the quarter, daily sales through eProcurement rose 19.3%, while daily sales via eCommerce declined 4.2%.In the second quarter of 2025, Digital Footprint sales (which include FMI technology and non-FMI eBusiness) accounted for 61% of total sales, up from 59.4% in the year-ago period. The company's revised 2025 target for Digital Footprint penetration is 63%–64%, down from the prior goal of 66%–68%. The gross margin was 45.3% in the reported quarter, up 20 bps year over year. Our model predicted a gross margin of 44.9% for the quarter. This upside was due to increased fastener product availability, which resulted in higher sales and improved gross general and administrative expenses – as a percentage of net sales – improved to 24.4% from 24.9% reported in the year-ago quarter. Our model predicted SG&A expenses to improve to 24.3%.Operating margin was 21% (higher than our projection of 20.6%), up from 20.2% a year ago. As of June 30, 2025, Fastenal had cash and cash equivalents of $237.8 million, down from $255.8 million as of Dec. 31, 2024. The long-term debt at the end of the second quarter of 2025 was $100 million, down from $125 million at 2024-end. During the quarter, FAST returned $252.5 million to its shareholders in the form of the second quarter of 2025, net cash provided by operating activities totaled $278.6 million, up 8.1% from the year-ago period. Fastenal currently carries a Zacks Rank #3 (Hold).Here are some better-ranked stocks from the Zacks Industrial Products Industrial Direct Co., Inc. MSM currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks MSC stock has gained 21% year to date (YTD). The company has a trailing four-quarter earnings surprise of 6%, on average. The Zacks Consensus Estimate for MSC's fiscal 2025 sales and EPS indicates a decline of 1.9% and 24.1%, respectively, from the year-ago period's Limited IPX currently carries a Zacks Rank #2 (Buy). IperionX stock has lost 4.4% YTD. The Zacks Consensus Estimate for IperionX's current year's bottom line is expected to improve to a loss of 2 cents per share compared with a 10-cent loss reported in the year-ago Aktiengesellschaft SIEGY currently carries a Zacks Rank #2. Siemens stock has gained 34.9% YTD. The Zacks Consensus Estimate for Siemens' current year's sales and EPS indicates growth of 2.3% and 20.5%, respectively, from the year-ago period's levels. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Fastenal Company (FAST) : Free Stock Analysis Report MSC Industrial Direct Company, Inc. (MSM) : Free Stock Analysis Report Siemens AG (SIEGY) : Free Stock Analysis Report IperionX Limited Sponsored ADR (IPX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
